Skip to main content
An official website of the United States government
Email

Artificial Intelligence (AI) in Cancer Research Funding Opportunities

AI research is funded through a wide variety of grant and contract programs across NCI, where the majority of cancer research is supported through broad-based, investigator-initiated grant opportunities. The following programs have a strong emphasis on AI:

Specific open Funding Opportunities and Requests for Information are listed in the table below.

Notices of Funding Opportunities and Requests for Information
Title Announcement Number Opening Date Expiration Date Activity Code
Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research NOT-CA-22-037 Jan 28, 2022 Mar 9, 2024 (See NOSI)
Notice of Special Interest (NOSI): Administrative Supplements to Support the Development of Digital Twins in Radiation Oncology (DTRO) NOT-CA-24-015 Dec 8, 2023 Mar 21, 2024 R00, R01, R21, R35, R37, U01, P01, P30, P50, U19, U24, or U54
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) RFA-CA-24-016 May 11, 2024 Nov. 16, 2024 R21
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) RFA-CA-24-017 May 11, 2024 Nov. 16, 2024 U01
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) RFA-CA-24-018 May 11, 2024 Nov. 16, 2024 U24
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) RFA-CA-24-019 May 11, 2024 Nov. 16, 2024 U24
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) NSF 23-614   Oct 3, 2024 (See NOFO)
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01—Clinical Trial Not Allowed) PAR-21-166 May 5, 2021 May 8, 2024 R01
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) PAR-23-259 Sep 5, 2023 Jan 8, 2027 R01
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) PAR-22-090 Jan 16, 2022 Jan 8, 2025 R21
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) PAR-22-091 Jan 16, 2022 Jan 8, 2025 R21
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) PAR-22-242 Oct 1, 2022 Sep 8, 2025 R01
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) PAR-22-243 Oct 1, 2022 Sep 8, 2025 R01
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional) PAR-22-131 Sep 5, 2022 Sep 8, 2025 R01

 

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Artificial Intelligence (AI) in Cancer Research Funding Opportunities was originally published by the National Cancer Institute.”

Email